Page 1

Exhibit 99.1 Highlights : • • • • Agilent Reports First - Quarter Fiscal Year 2021 Financial Results Strong start to 2021 , raising full - year guidance Revenue of $ 1.55 billion represents an increase of 14 % reported growth year over year , up 11 % on a core ( 1 ) basis . • GAAP net income of $ 288 million , or 93 cents per share . • Non - GAAP ( 2 ) net income of $ 328 million , or $ 1.06 per share . Full - year guidance raised with revenue now expected to be in the range of $ 5.825 billion to $ 5.900 billion and non - GAAP ( 3 ) earnings per share ( EPS ) of $ 3.80 to $ 3.90 . Second - quarter revenue expected to be in the range of $ 1.37 billion to $ 1.39 billion with non - GAAP ( 3 ) EPS of 78 cents to 80 cents . Agilent Board of Directors authorizes new $ 2 billion share repurchase program . - SANTA CLARA , Calif . , Feb. 16 , 2021 – Agilent Technologies Inc. ( NYSE : A ) today reported revenue of $ 1.55 billion for the first quarter ended Jan. 31 , 2021 , an increase of 14 % compared to the first quarter of 2020 and up 11 % on a core ( 1 ) basis . First - quarter GAAP net income was $ 288 million , or 93 cents per share . This compares with $ 197 million , or 63 cents per share , in the first quarter of fiscal year 2020. Non - GAAP ( 2 ) net income was $ 328 million , or $ 1.06 per share compared with $ 252 million , or 81 cents per share , during the first quarter a year ago . " Agilent's performance in the first quarter was outstanding and exceeded our recently increased revenue expectations , " said Mike McMullen , Agilent president and CEO . “ Our revenue growth was broad based with all three business groups growing double - digits . The Agilent team stayed focused , executed extremely well and increased market share in key areas . Our ‘ build and buy ' strategy is delivering for us and the outlook for the remainder of the year is quite strong . " Financial Highlights Life Sciences and Applied Markets Group First - quarter revenue of $ 722 million from Agilent's Life Sciences and Applied Markets Group ( LSAG ) was up 13 % year over year and 11 % on a core ( 1 ) basis . LSAG's operating margin was 27.6 % . Agilent CrossLab Group First - quarter revenue of $ 532 million from the Agilent CrossLab Group ( ACG ) increased 13 % year over year and was up 10 % on a core ( 1 ) basis . ACG's operating margin was 26.7 % . Diagnostics and Genomics Group First - quarter revenue of $ 294 million from Agilent's Diagnostics and Genomics Group ( DGG ) increased 18 % year over year and was up 15 % on a core ( 1 ) basis . DGG's operating margin was 18.6 % . 1